XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.23.1

Mezzanine Equity | 3 Months Ended
--- | ---
Apr. 01, 2023
Stockholders' Equity Note [Abstract] |
Mezzanine Equity | Note 14: Mezzanine Equity Series S Preferred Stock On December 28, 2022 the Company acquired Soin Therapeutics by way of merger. In connection with this transaction, with a potential value of up to $30 million, the Company tendered 100,000 shares of the Company's Series S Convertible Preferred Stock. Shares of Series S Convertible Preferred Stock are convertible into the Company’s common shares at a ratio of 1:1. As of April 1, 2023 and December 31, 2022, there were 100,000 shares of Series S Convertible Preferred Stock outstanding.

X
- Definition Mezzanine Equity Text Block + References No definition available. + Details
Name: | jan_MezzanineEquityTextBlock
Namespace Prefix: | jan_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration